Spot on Mattilla... and the cost curve advantages of the Hombre Muerto chemistry (ie high Li readings and low Mg ratios) were very much a talking point with potential investors at yesterday's RIU, ie the low OPEX that comes with HM provides a great advantage/buffer from Li price fluctuations.
And yes, @Broken chair, I agree with you. IMO, the investment decision for GLN (or many other Li companies) doesn't hinge on hydroxide, carbonate, ponds or direct extraction - rather, it's weighing up the quality of both the resource and the management team.
And I expect funds know exactly that! JP was bailed up for quite a while as soon as he left the room after his presentation, and it took him a while to be able to make his way back to the booth.
Let's not forget, JP used to work for Patterson's... there were a few people yesterday at RIU who already knew who JP was. And Terry Gardiner is a director with Barclay Wells. Between them, I expect they'll be fielding a fair few enquiries from Funds looking them over.
The first drill results have confirmed there's Li in the brine (and lots of it!). IMO, the second drill results will seal the deal ....
As JP said yesterday, and I expect the funds paid attention to, "this isn't going to be small" and they're "setting up for something big".
GLN Price at posting:
40.5¢ Sentiment: Hold Disclosure: Held
(20min delay)
